PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Given the genetic heritability of NAFLD and the fact that lifestyle modification is the cornerstone of treatment for risk reduction (24), efforts to improve knowledge and awareness of PNPLA3 risk status are important to inform therapeutic lifestyle strategies.